Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Scanner To Be Made Available To Aus & NZ

Scanner To Be Made Available To Several European Countries, Australia And New Zealand

Media Release From Applied Precision, Inc.


ISSAQUAH, Wash., and FREIBURG, Germany, March 19 /PRNewswire-AsiaNet/ -- GeneScan Europe AG will be the exclusive distributor of Applied Precision, Inc.'s arrayWoRx Microarray Scanner in several European countries, Australia, and New Zealand. Thanks to GeneScan's broad reach, the arrayWoRx Microarray Scanner will now be available to academic research customers and the biotechnology and pharmaceutical industries in these countries.

(Photo: http://www.newscom.com/cgi-bin/prnh/19990804/APLOGO )

"GeneScan is a major player in applied molecular biology in Europe, which will provide invaluable assistance to us in expanding our market share in these countries," said Joe Ahladis, Vice President of Sales, Marketing and Customer Service for Applied Precision.

BioChip Technologies GmbH, a subsidiary of GeneScan Europe, has already taken advantage of arrayWoRx's multi-color flexibility and highly precise image acquisition and analysis in its research and development department. Dr. Roland Toder, Chief Science Officer for GeneScan, touts the scanner's performance in more complex biochip applications. "Whereas our proprietary microarray reader Biodetect(R) is used for fast standardized routine measurements, the high-end arrayWoRx is applied to arrays of higher density and larger formats."

Roman Kluson, European Sales Manager of GeneScan Europe, said, "We're always looking for the best tools to offer to our customers, and the advanced speed and accuracy the arrayWoRx system provides is sure to help them conduct better research and more efficient production. Our strategic alliance with Applied Precision is a long-term partnership which guarantees our customers continuity of business relations and technical support."

About GeneScan Europe AG GeneScan Europe AG (www.genescan.de) is a leading provider of products and services in applied molecular biology. The company develops, produces and markets high-quality biochips with low to medium spot densities. These biochips are customized according to client specifications or designed for routine applications in an emerging analytical mass market. The core businesses of GeneScan Europe are food analysis, medical diagnosis, environmental analysis, and livestock and plant breeding analysis. The GeneScan group currently consists of a global network of thirteen innovative and fast-growing biotechnology companies.

About Applied Precision Applied Precision develops measurement, analysis and process control systems for biomedical and biotechnology imaging and analysis systems (especially live-cell microscopy, genomics and proteomics), semiconductor wafer test and precision motion control components. Applied Precision's specialized products are based on precisionware(TM), the company's unique convergence of mechanics, electronics, optics and software. Applied Precision, Inc. has been enabling advancements in the world's core technologies since its inception in 1985. Applied Precision (www.appliedprecision.com) can be reached in the United States at (425) 557-1000 or in the United Kingdom at +44 1672 518350.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Elsewhere:


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>